Carlquist J F, Ward R H, Husebye D, Feolo M, Anderson J L
Department of Medicine, University of Utah, Salt Lake City.
Am J Cardiol. 1994 Nov 1;74(9):918-20. doi: 10.1016/0002-9149(94)90586-x.
Certain immunologic features associated with idiopathic dilated cardiomyopathy (IDC) suggest an infectious and/or autoimmune etiology. In this regard, an association between the major histocompatibility complex class II allele, DR4, and increased risk for IDC was previously identified. In the present report, 43 additional patients with IDC and 236 control subjects were studied for major histocompatibility class II allele associations. DR alleles were identified by microcytotoxicity. No significant differences between control subjects and patients with IDC were seen, although the frequency of DR4 was increased among patients. DR4 subtyping (n = 9) was performed by "dot blot" hybridization of allele-specific oligonucleotide probes to PCR-amplified genomic deoxyribonucleic acid. The DRB10401 and DRB10404 alleles were each found in 44% (n = 4) of patients with IDC, and DRB10407 was identified in 1 patient (11%). DQ and DP alleles were identified by restriction endonuclease codigestion of polymerase chain reaction-amplified deoxyribonucleic acid. The digested fragments were separated and identified by polyacrylamide gel electrophoresis. Differences between patients and control subjects were observed for DQA10501 (11% of patients vs 28% of control subjects, p < 0.05) and DQB10201 (13% patients vs 25% control subjects, p < 0.05). A modest difference was noted for DQA10301 (35% patients vs 23% control subjects, p = 0.08). These findings suggest a complex immune-related etiology for IDC that cannot be explained solely by the presence or absence of a single class II allele. However, this and other studies continue to implicate genes within the class II region in determining the risk for IDC.
某些与特发性扩张型心肌病(IDC)相关的免疫学特征提示其病因可能与感染和/或自身免疫有关。在这方面,先前已确定主要组织相容性复合体II类等位基因DR4与IDC风险增加之间存在关联。在本报告中,对另外43例IDC患者和236例对照受试者进行了主要组织相容性复合体II类等位基因关联研究。通过微量细胞毒性鉴定DR等位基因。尽管患者中DR4的频率有所增加,但在对照受试者和IDC患者之间未观察到显著差异。通过等位基因特异性寡核苷酸探针与聚合酶链反应扩增的基因组脱氧核糖核酸进行“斑点印迹”杂交对DR4进行亚型分析(n = 9)。在44%(n = 4)的IDC患者中均发现了DRB10401和DRB10404等位基因,在1例患者(11%)中鉴定出DRB10407。通过聚合酶链反应扩增的脱氧核糖核酸的限制性内切酶酶切鉴定DQ和DP等位基因。通过聚丙烯酰胺凝胶电泳分离和鉴定消化后的片段。在DQA10501(患者中为11%,对照受试者中为28%,p < 0.05)和DQB10201(患者中为13%,对照受试者中为25%,p < 0.05)方面观察到患者与对照受试者之间存在差异。在DQA10301方面观察到适度差异(患者中为35%,对照受试者中为23%,p = 0.08)。这些发现提示IDC存在复杂的免疫相关病因,不能仅通过单个II类等位基因的存在或缺失来解释。然而,本研究及其他研究继续表明II类区域内的基因在确定IDC风险方面具有重要作用。